Hirano, I. (2016). 2015 David Y. Graham Lecture: The first two decades of eosinophilic esophagitis – from acid reflux to food allergy. The American Journal of Gastroenterology, 111, 770–776.
Furuta, G. T., Liacouras, C. A., Collins, M. H., Gupta, S. K., Justinich, C., Putnam, P. E., Bonis, P., Hassall, E., Straumann, A., & Rothenberg, M. E. (2007). Eosinophilic esophagitis in children and adults: A systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology, 133, 1342–1363.
Article
CAS
PubMed
Google Scholar
DeBrosse, C. W., Franciosi, J. P., King, E. C., Buckmeier Butz, B. K., Greenberg, A. B., Collins, M. H., Abonia, J. P., Assa'ad, A., Putnam, P. E., & Rothenberg, M. E. (2011). Long-term outcomes in pediatric-onset esophageal eosinophilia. The Journal of Allergy and Clinical Immunology, 128, 132–138.
Article
PubMed
PubMed Central
Google Scholar
Schoepfer, A., Safroneeva, E., Bussmann, C., Kuchen, T., Portmann, S., Simon, H. U., & Straumann, A. (2013). Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology, 145, 1230–1236.
Article
PubMed
Google Scholar
Dellon, E. S., Jensen, E. T., Martin, C. F., Shaheen, N. J., & Kappelman, M. D. (2014). Prevalence of eosinophilic esophagitis in the United States. Clinical Gastroenterology and Hepatology, 12, 589–596.
Article
PubMed
Google Scholar
Arias, A., Perez-Martinez, I., Tenias, J. M., & Lucendo, A. J. (2016). Systematic review with meta-analysis: The incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Alimentary Pharmacology & Therapeutics, 43, 3–15.
Article
CAS
Google Scholar
Jensen, E. T., Kappelman, M. D., Martin, C. F., & Dellon, E. S. (2015). Health-care utilization, costs, and the burden of disease related to eosinophilic esophagitis in the United States. The American Journal of Gastroenterology, 110, 626–632.
Article
PubMed
Google Scholar
Liacouras, C. A., Furuta, G. T., Hirano, I., Atkins, D., Attwood, S. E., Bonis, P. A., Burks, A. W., Chehade, M., Collins, M. H., Dellon, E. S., et al. (2011). Eosinophilic esophagitis: Updated consensus recommendations for children and adults. The Journal of Allergy and Clinical Immunology, 128, 3–20 e26.
Article
PubMed
Google Scholar
Gupta, S. K., Vitanza, J. M., & Collins, M. H. (2015). Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis. Clinical Gastroenterology and Hepatology, 13, 66–76 e63.
Article
CAS
PubMed
Google Scholar
Dellon, E. S., Katzka, D. A., Collins, M. H., Hamdani, M., Gupta, S. K., & Hirano, I. (2017). Budesonide oral suspension improves symptomatic, endoscopic, and histologic parameters compared with placebo in patients with eosinophilic esophagitis. Gastroenterology, 152, 776–786.
Dellon, E. S., Katzka, D. A., Collins, M. H., Hamdani, M., Gupta, S. K., & Hirano, I. (2016). Safety and efficacy of oral budesonide suspension for maintenance therapy in eosinophilic esophagitis: Results from a prospective open-label study of adolescents and adults. Gastroenterology, 150 (Supplement 1), S188.
Dellon, E. S., Irani, A. M., Hill, M. R., & Hirano, I. (2013). Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis. Alimentary Pharmacology & Therapeutics, 38, 634–642.
Article
CAS
Google Scholar
Cappelleri, J. C., Zou, K. H., Bushmakin, A. G., Alvir, J. M. J., Alemayehu, D., & Symonds, T. (2013). Patient-reported outcomes: Measurement, implementation and interpretation. Chapman and Hall/CRC.
Bonett, D. G., & Wright, T. A. (2000). Sample size requirements for Pearson, Kendall, and Spearman correlations. Psychometrika, 65, 23–28.
Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory (pp. 248–292). New York: McGraw-Hill Inc.
Google Scholar
Cohen, J. (1977). Statistical power analysis for the behavioural sciences. New York: Academic Press.
Google Scholar
Hedges, L., & Olkin, I. (1985). Statistical methods for meta-analysis. Waltham, Massachusetts: Academic Press.
Google Scholar
Kudar, G. F., & Richardson, M. W. (1937). The theory of the estimation of test reliability. Psychometrika, 2, 151–160.
Article
Google Scholar
Revicki, D. A., Erickson, P. A., Sloan, J. A., Dueck, A., Guess, H., & Santanello, N. C. (2007). Interpreting and reporting results based on patient-reported outcomes. Value Health, 10 (Supplement 2), S116–S124.
Hirano, I., Katzka, D. A., Collins, M. H., & Dellon, E. S. (2015). Randomized, double-blind, placebo controlled trial demonstrates the efficacy of oral budesonide suspension in improving endoscopically identified esophageal abnormalities in eosinophilic esophagitis. Gastroenterology, 148, S-29–S-30.
Alexander, J. A., Jung, K. W., Arora, A. S., Enders, F. B., Katzka, D. A., Kephardt, G. M., Kita, H., Kryzer, L. A., Romero, Y., Smyrk, T. C., & Talley, N. J. (2012). Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clinical Gastroenterology and Hepatology, 10, 742–749 e741.
Article
CAS
PubMed
Google Scholar
Pentiuk, S., Putnam, P. E., Collins, M. H., & Rothenberg, M. E. (2009). Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. Journal of Pediatric Gastroenterology and Nutrition, 48, 152–160.
Article
PubMed
PubMed Central
Google Scholar
Hruz, P. (2014). Epidemiology of eosinophilic esophagitis. Digestive Diseases, 32, 40–47.
Konikoff, M. R., Noel, R. J., Blanchard, C., Kirby, C., Jameson, S. C., Buckmeier, B. K., Akers, R., Cohen, M. B., Collins, M. H., Assa'ad, A. H., et al. (2006). A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology, 131, 1381–1391.
Article
CAS
PubMed
Google Scholar
Dohil, R., Newbury, R., Fox, L., Bastian, J., & Aceves, S. (2010). Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology, 139, 418–429.
Article
CAS
PubMed
Google Scholar
Spergel, J. M., Rothenberg, M. E., Collins, M. H., Furuta, G. T., Markowitz, J. E., Fuchs, G., 3rd, O'Gorman, M. A., Abonia, J. P., Young, J., Henkel, T., et al. (2012). Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial. The Journal of Allergy and Clinical Immunology, 129, 456–463 e451−453.
Straumann, A., Conus, S., Grzonka, P., Kita, H., Kephart, G., Bussmann, C., Beglinger, C., Smith, D. A., Patel, J., Byrne, M., & Simon, H. U. (2010). Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: A randomised, placebo-controlled, double-blind trial. Gut, 59, 21–30.
McElhiney, J., Lohse, M. R., Arora, A. S., Peloquin, J. M., Geno, D. M., Kuntz, M. M., Enders, F. B., Fredericksen, M., Abdalla, A. A., Khan, Y., et al. (2010). The Mayo Dysphagia Questionnaire-30: Documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. Dysphagia, 25, 221–230.
Franciosi, J. P., Hommel, K. A., DeBrosse, C. W., Greenberg, A. B., Greenler, A. J., Abonia, J. P., Rothenberg, M. E., & Varni, J. W. (2011). Development of a validated patient-reported symptom metric for pediatric eosinophilic esophagitis: Qualitative methods. BMC Gastroenterology, 11, 126.
Article
PubMed
PubMed Central
Google Scholar
Varni, J. W., Seid, M., & Kurtin, P. S. (2001). PedsQL 4.0: Reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Medical Care, 39, 800–812.
Article
CAS
PubMed
Google Scholar
Franciosi, J. P., Hommel, K. A., Bendo, C. B., King, E. C., Collins, M. H., Eby, M. D., Marsolo, K., Abonia, J. P., von Tiehl, K. F., Putnam, P. E., et al. (2013). PedsQL eosinophilic esophagitis module: Feasibility, reliability, and validity. Journal of Pediatric Gastroenterology and Nutrition, 57, 57–66.
Article
PubMed
PubMed Central
Google Scholar
Kwiatek, M. A., Kiebles, J. L., Taft, T. H., Pandolfino, J. E., Bove, M. J., Kahrilas, P. J., & Keefer, L. (2011). Esophageal symptoms questionnaire for the assessment of dysphagia, globus, and reflux symptoms: Initial development and validation. Diseases of the Esophagus, 24, 550–559.
Article
CAS
PubMed
Google Scholar
Taft, T. H., Kern, E., Kwiatek, M. A., Hirano, I., Gonsalves, N., & Keefer, L. (2011). The adult eosinophilic oesophagitis quality of life questionnaire: A new measure of health-related quality of life. Alimentary Pharmacology & Therapeutics, 34, 790–798.
Article
CAS
Google Scholar
U.S. Department of Health and Human Services FDA (2009). Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Available from: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf. Accessed 1 Aug 2017.
Stull, D. E., Leidy, N. K., Parasuraman, B., & Chassany, O. (2009). Optimal recall periods for patient-reported outcomes: Challenges and potential solutions. Current Medical Research and Opinion, 25, 929–942.
Article
PubMed
Google Scholar
Martin, L. J., Franciosi, J. P., Collins, M. H., Abonia, J. P., Lee, J. J., Hommel, K. A., Varni, J. W., Grotjan, J. T., Eby, M., He, H., et al. (2015). Pediatric eosinophilic esophagitis symptom scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease. The Journal of Allergy and Clinical Immunology, 135, 1519–1528 e1518.
Article
PubMed
PubMed Central
Google Scholar
Wright, A., Hannon, J., Hegedus, E. J., & Kavchak, A. E. (2012). Clinimetrics corner: A closer look at the minimal clinically important difference (MCID). The Journal of Manual & Manipulative Therapy, 20, 160–166.
Menard-Katcher, P., Marks, K. L., Liacouras, C. A., Spergel, J. M., Yang, Y. X., & Falk, G. W. (2013). The natural history of eosinophilic oesophagitis in the transition from childhood to adulthood. Alimentary Pharmacology & Therapeutics, 37, 114–121.
Article
CAS
Google Scholar